BioSpace News Archive

BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neurodegenerative disorders and certain cancers, announced today that a video documentary detailing the development history of the Company’s newly acquired NE3107 asset will be featured in the American Diabetes Association’s Thought Leadership Film Series on ADA TV,

Kane Biotech Inc. will host investor meetings at the 10th AnnualWhistler 2021 Capital Conference hosted by Capital Event Management the weekend of July 9-11, 2021 at The Fairmont Chateau, Whistler.

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2021 on Tuesday, July 27, 2021 at 8:00 a.m. EDT .

Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce FDA 510(k) clearance of its Aptiva® System and Aptiva® Celiac Disease IgA assay.

This amendment approval from Health Canada will facilitate the study and permit achieving the required sample size in a timely manner.

The first half of 2021 has seen a dramatic shift in the COVID-19 marketplace in the United States,” said Gerald E. Commissiong, President & CEO of Todos Medical.

As a Co-Sell Ready Microsoft partner, the company’s specialty drug enrollment solution will be jointly sold with Microsoft sales teams and in Microsoft’s commercial marketplace, opening the door to rapid expansion of the reach and deployment of RxLightning technology.

The report highlights the trends prevailing in the market, along with market drivers and deterrents.

The global electrosurgical devices market is expected to reach US$ 8,000.9 Mn in 2025 from US$ 4,828.4 Mn in 2017.

The report highlights the trends prevalent in the global gynecology devices market and the factors driving the market along with those that act as deterrents to its growth.